We are live on ! Find out more
PC

Promethos Capital Portfolio holdings

AUM $368M
1-Year Est. Return 27.67%
This Fund
S&P 500
This Quarter Est. Return
+0.91%
1 Year Est. Return
+27.67%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$283M
AUM Growth
+$2.63M
Cap. Flow
+$6.21M
Cap. Flow %
2.19%
Top 10 Hldgs %
47.87%
Holding
89
New
9
Increased
34
Reduced
3
Closed
7
Avg Time Held
3.1 quarters
Top 10 Avg Time Held
3 quarters
Top 20 Avg Time Held
3.2 quarters

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$4.61M
2
KMB icon
Kimberly-Clark
KMB
+$3.67M
3
GDDY icon
GoDaddy
GDDY
+$3.08M
4
NTAP icon
NetApp
NTAP
+$2.74M
5
STRL icon
Sterling Infrastructure
STRL
+$1.73M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$5.98M
2
AVGO icon
Broadcom
AVGO
+$5.41M
3
TGT icon
Target
TGT
+$4.33M
4
CIG icon
CEMIG Preferred Shares
CIG
+$563K
5
HSBC icon
HSBC
HSBC
+$116K

Sector Composition

Rank Sector Weight
1 Technology 37.11%
2 Financials 23.13%
3 Healthcare 14.43%
4 Industrials 7.99%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SAP icon
1
SAP
SAP
$241B
$29.1M 10.29%
118,357
+3,708
+3% +$882K
2023 Q4
4 quarters
TSM icon
2
TSMC
TSM
$2.45T
$18.7M 6.61%
94,804
+750
+0.8% +$145K
2024 Q2
2 quarters
NVS icon
3
Novartis
NVS
$268B
$15.2M 5.36%
156,088
+15,012
+11% +$1.6M
2024 Q1
3 quarters
MFC icon
4
Manulife Financial
MFC
$71.1B
$12.8M 4.53%
417,645
– –
2023 Q4
4 quarters
IBN icon
5
ICICI Bank
IBN
$98.5B
$12M 4.24%
402,585
+2,300
+0.6% +$69.4K
2023 Q4
4 quarters
RDY icon
6
Dr. Reddy's Laboratories
RDY
$10.2B
$10.7M 3.77%
677,184
+3,514
+0.5% +$52.8K
2023 Q4
4 quarters
WIT icon
7
Wipro
WIT
$17B
$9.89M 3.49%
2,793,938
– –
2023 Q4
4 quarters
AAPL icon
8
Apple
AAPL
$4.87T
$9.54M 3.37%
38,080
+1,330
+4% +$313K
2024 Q2
2 quarters
GIB icon
9
CGI
GIB
$14.5B
$9.35M 3.3%
85,484
+1,040
+1% +$117K
2023 Q4
4 quarters
MSFT icon
10
Microsoft
MSFT
$3.84T
$8.23M 2.91%
19,530
+660
+3% +$281K
2023 Q4
4 quarters
HSBC icon
11
HSBC
HSBC
$329B
$7.93M 2.8%
160,253
-2,501
-2% -$116K
2023 Q4
4 quarters
NFLX icon
12
Netflix
NFLX
$279B
$6.64M 2.35%
74,540
+2,500
+3% +$206K
2024 Q2
2 quarters
CNI icon
13
Canadian National Railway
CNI
$72.4B
$6.61M 2.33%
65,070
– –
2023 Q4
4 quarters
NTR icon
14
Nutrien
NTR
$33.4B
$6.54M 2.31%
146,168
+1,100
+0.8% +$52.2K
2023 Q4
4 quarters
SHG icon
15
Shinhan Financial Group
SHG
$36.6B
$6.5M 2.3%
197,716
+1,900
+1% +$73.5K
2023 Q4
4 quarters
KB icon
16
KB Financial Group
KB
$43.5B
$6.28M 2.22%
110,291
– –
2023 Q4
4 quarters
CRM icon
17
Salesforce
CRM
$193B
$6.01M 2.12%
17,990
+630
+4% +$201K
2024 Q3
1 quarter
UBS icon
18
UBS Group
UBS
$146B
$5.63M 1.99%
185,831
– –
2024 Q1
3 quarters
OC icon
19
Owens Corning
OC
$9.36B
$5.56M 1.96%
32,627
+1,110
+4% +$207K
2023 Q4
4 quarters
IRM icon
20
Iron Mountain
IRM
$33.8B
$5.48M 1.93%
52,122
+1,780
+4% +$209K
2023 Q4
4 quarters
HIG icon
21
Hartford Financial Services
HIG
$34.1B
$5.19M 1.83%
47,469
+1,590
+3% +$184K
2023 Q4
4 quarters
SKM icon
22
SK Telecom
SKM
$14.1B
$4.97M 1.76%
236,360
– –
2024 Q1
3 quarters
WSM icon
23
Williams-Sonoma
WSM
$27.4B
$4.8M 1.7%
25,928
+850
+3% +$135K
2023 Q4
4 quarters
BMY icon
24
Bristol-Myers Squibb
BMY
$125B
$4.73M 1.67%
83,709
+82,515
+6,911% +$4.61M
2023 Q4
4 quarters
BNY
25
Bank of New York Mellon
BNY
$98.7B
$4.56M 1.61%
59,406
+2,000
+3% +$155K
2024 Q2
2 quarters
1
2 3 4

Similar funds

1CP
11 Capital Partners Darien, Connecticut $368M AUM 30.26% 1-Year Est. Return
SFP
Sterling Financial Planning Sparta, New Jersey $368M AUM 22.51% 1-Year Est. Return
FZCM
Flynn Zito Capital Management Garden City, New York $368M AUM 37.57% 1-Year Est. Return
FPL
Fortress Private Ledger Raleigh, North Carolina $368M AUM 39.86% 1-Year Est. Return
BCC
Bain Capital Credit Boston, Massachusetts $368M AUM 9.33% 1-Year Est. Return
NWWA
New Wave Wealth Advisors Springdale, Arkansas $367M AUM 36.16% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $368M AUM 20.94% 1-Year Est. Return
OAP
One Advisory Partners Overland Park, Kansas $367M AUM 19.94% 1-Year Est. Return

Promethos Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Promethos Capital held 89 positions worth $283M, up 0.94% from $281M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Promethos Capital's Q4 2024 filing shows 9 new, 34 increased, 3 reduced and 7 closed positions. Its largest new stake was Kimberly-Clark: 26,940 shares worth $3.53M. The largest sale was AbbVie, an estimated $5.98M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.

  • Promethos Capital's largest Q4 2024 buy was Kimberly-Clark: 26,940 shares worth $3.53M.
  • Promethos Capital added most to Bristol-Myers Squibb in Q4 2024, an estimated $4.61M increase.
  • Promethos Capital's biggest Q4 2024 reduction was CEMIG Preferred Shares, cutting an estimated $563K.
  • Promethos Capital fully exited AbbVie in Q4 2024, selling an estimated $5.98M.
  • Promethos Capital's ten largest holdings make up 48% of its $283M portfolio in Q4 2024.
  • Promethos Capital opened 9 new positions and closed 7 in Q4 2024.
  • Promethos Capital's portfolio value rose 0.94% quarter-over-quarter to $283M.

Based on Promethos Capital's 13F filing for Q4 2024, filed 13 Feb 2025.